Skip to Main Content

Author Details

Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
2009
29
17
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35128980Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.Toxicol Pathol2022
35867415Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza.Microbiol Spectr2022
32661015Induction and Evasion of Type-I Interferon Responses during Influenza A Virus Infection.Cold Spring Harb Perspect Med2021
33495306Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.Science2021
33882122IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization.J Exp Med2021
33501468The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera.medRxiv2021
34517409Virus-induced senescence is a driver and therapeutic target in COVID-19.Nature2021
33975931Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics.mBio2021
31189111N-Glycolylneuraminic Acid as a Receptor for Influenza A Viruses.Cell Rep2019
31851929Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses.Cell Rep2019
31375585Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1.J Virol2019
29321309Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.J Virol2018
29872540Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.Cell Discov2018
29624387Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.J Med Chem2018
27890675Synergistic drug combination effectively blocks Ebola virus infection.Antiviral Res2017
29203926Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death.Nat Commun2017
27116236Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection.PLoS One2016
27895186Correction for Eduardo-Correia et al., ISG15 Is Counteracted by Vaccinia Virus E3 Protein and Controls the Proinflammatory Response against Viral Infection.J Virol2016
25888743Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.J Transl Med2015
26057711Against the clock towards new Ebola virus therapies.Virus Res2015
24257616ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.J Virol2014
26038505Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs.Emerg Microbes Infect2014
25211074The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon.Cell Host Microbe2014
24742605The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells.Oncotarget2014
24882218Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response.Immunity2014
23192878Mouse dendritic cell (DC) influenza virus infectivity is much lower than that for human DCs and is hemagglutinin subtype dependent.J Virol2013
24109242Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions.J Virol2013
23536663Substitutions T200A and E227A in the hemagglutinin of pandemic 2009 influenza A virus increase lethality but decrease transmission.J Virol2013
19585519The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.J Pathol2009
  • 1 - 29 of 29

Recommended Authors

University of Maryland School of Medicine
Career Start Year 2014
Number of shared co-authors 12
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 3
Institute of Medical Virology, University of Zurich
Career Start Year 2012
Number of shared co-authors 15
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2012
Number of shared co-authors 5
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 14
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 2
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 4
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 7
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 1
Rutgers University
Career Start Year 2007
Number of shared co-authors 4
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2006
Number of shared co-authors 0
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 10
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 5
University of California san francisco
Career Start Year 2006
Number of shared co-authors 10
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 3
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 2
University of Iowa
Career Start Year 2002
Number of shared co-authors 18
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 25
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 21
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 8
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 22
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 8
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 15
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 1993
Number of shared co-authors 3
University College London
Career Start Year 1992
Number of shared co-authors 10
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 1
University of North Carolina
Career Start Year 1981
Number of shared co-authors 6
Influenza Research Institute, University of Wisconsin
Career Start Year 1979
Number of shared co-authors 6

Collaborators

Icahn School of Medicine at Mount Sinai
Co-authored papers 27
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
NYU Grossman School of Medicine
Co-authored papers 3
Institute of Veterinary Disease Control
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 3
University of Geneva
Co-authored papers 3
Institute of Medical Virology, University of Zurichgrid.0.3
Co-authored papers 2
University of Texas Medical Branch
Co-authored papers 2
University of South Florida
Co-authored papers 2
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Icahn School of Medicine at Mount Sinaigrid.59734.3c
Co-authored papers 2
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Institute of Medical Virology, University of Zurich
Co-authored papers 2
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Charite - Universitatsmedizin Berlin
Co-authored papers 1
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Korea University College of Medicine
Co-authored papers 1
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 1
Hospital Infantil Universitario "La Paz"
Co-authored papers 1